Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 45 Show results per page	View Search Criteria \| Help With Results


1.		Phase II/III Chemotherapy with ICRF-187 for Disseminated Colorectal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								UMCT-1380

Last Modified: 3/1/2000


2.		Phase IIIB Randomized Study of Doxorubicin plus the Cardioprotectant Dexrazoxane vs Observation in Women with Advanced Breast Cancer That is Stable or Responding After 6 Courses of First-Line Cyclophosphamide/Doxorubicin/Fluorouracil (CAF) (Summary Last Modified 03/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				18 and over				Pharmaceutical / Industry				PHARMACIA-088050 NCI-V96-0828

Last Modified: 11/21/2005


3.		Phase III Randomized Study of Intensive Therapy for T-Cell Acute Lymphoblastic Leukemia and Advanced Lymphoblastic Non-Hodgkin's Lymphoma (the T-4 Study): Multiagent Chemotherapy with vs without Dexrazoxane Cardioprotection and with vs without High-Dose MTX

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				0 to 21				NCI				POG-9404 POG-9404

Last Modified: 5/8/2007 First Published: 10/1/1996


4.		Phase III Randomized Study of Response-Dependent Therapy with Doxorubicin/Bleomycin/Vincristine/Etoposide (DBVE) with vs without Dexrazoxane Followed by Low-Dose Involved-Field Radiotherapy for Newly Diagnosed Stage IA/IIA/IIIA1 Childhood Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				21 and under				NCI				POG-9426 CCG-P9426, NCT00002827, POG-9426

Last Modified: 5/14/2007 First Published: 3/1/1997


5.		Phase III Randomized Study of Combination Chemotherapy With or Without Dexrazoxane in Children With Advanced Stage Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				21 and under				NCI				COG-9425 NCT00005578, POG-9425

Last Modified: 11/7/2007 First Published: 12/1/1999


6.		Phase III Randomized Study of Chemotherapy and Radiotherapy in Children With Standard or High Risk Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				1 to 17				NCI				DFCI-95001 DFCI-FDR001197, NCI-G99-1651, NCT00004034

Last Modified: 5/18/2006 First Published: 8/1/1999


7.		Phase III Pilot Study of Three Intensification Regimens and Phase III Study of Intensification Therapy Plus Dexrazoxane in Patients With Newly Diagnosed, Nonmetastatic Osteosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				30 and under				NCI				COG-P9754 POG-P9754, COG-P9754, CCG-P9754, NCT00003937, P9754

Last Modified: 5/9/2007 First Published: 5/1/2000


8.		Phase III Pilot Randomized Study of Filgrastim-SD/01 Versus Filgrastim (G-CSF) With Concurrent Chemotherapy in Patients With Newly Diagnosed Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				25 and under at diagnosis				NCI				NCI-00-C-0092G AMGEN-20000124, NCT00020137

Last Modified: 8/2/2007 First Published: 5/1/2001


9.		Phase III Randomized Study of Doxorubicin and Cyclophosphamide With or Without Dexrazoxane, Followed By Paclitaxel With or Without Trastuzumab (Herceptin), Followed By Surgery and Radiotherapy With or Without Trastuzumab in Women With HER-2+ Stage IIIA or IIIB or Regional Stage IV Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				18 and over				NCI				CLB-49808 NCT00016276, CALGB-49808

Last Modified: 6/1/1997


10.		Phase III Randomized Trial of Cardioprotection with ICRF-187 in Patients with Advanced Breast Cancer Treated with FAC (5-FU/ADR/CTX) (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				NYU-8305 NCI-T83-1038D, T83-1038

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute